Double-Blind, Placebo-Controlled, Randomized, Crossover Trial of High-Dose Methylprednisolone in Patients with Chronic Progressive Form of Multiple Sclerosis

1995 ◽  
Vol 35 (4) ◽  
pp. 193-198 ◽  
Author(s):  
Giuseppe Cazzato ◽  
Tiziana Mesiano ◽  
Rodolfo Antonello ◽  
Fabrizio Monti ◽  
Nicola Carraro ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Crossover Trial ◽  
High Dose ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Randomized Crossover Trial ◽  
High Dose Methylprednisolone ◽  
Progressive Form

scholarly journals Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)

BMC Neurology ◽  
2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Marcus J. Drake ◽  
Luke Canham ◽  
Nikki Cotterill ◽  
Debbie Delgado ◽  
Jenny Homewood ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Crossover Trial ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study

CNS Drugs ◽  
2018 ◽  
Vol 32 (7) ◽  
pp. 661-672 ◽  
Author(s):  
Ayman Tourbah ◽  
Olivier Gout ◽  
Alain Vighetto ◽  
Véronique Deburghgraeve ◽  
Jean Pelletier ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Optic Neuritis ◽  
Visual Loss ◽  
Controlled Study ◽  
High Dose ◽  
Double Blind ◽  
Double Blind Placebo

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis

Neurology ◽  
1992 ◽  
Vol 42 (8) ◽  
pp. 1468-1468 ◽  
Author(s):  
B. G. Weinshenker ◽  
M. Penman ◽  
B. Bass ◽  
G. C. Ebers ◽  
G. P. A. Rice
Keyword(s):  
Multiple Sclerosis ◽  
Crossover Trial ◽  
Double Blind ◽  
Randomized Crossover Trial
Sign in / Sign up

Export Citation Format

Share Document